Macrocyclic compounds useful as bace inhibitors

Details for Australian Patent Application No. 2006205816 (hide)

Owner Novartis AG

Inventors Machauer, Rainer; Veenstra, Siem Jacob; Tintelnot-Blomley, Marina; Betschart, Claudia; Rueger, Heinrich; Lerchner, Andreas

Agent Davies Collison Cave

Pub. Number AU-A-2006205816

PCT Pub. Number WO2006/074950

Priority 0520165.2 04.10.05 GB; 0500682.0 13.01.05 GB

Filing date 13 January 2006

Wipo publication date 20 July 2006

International Classifications

C07D 245/04 (2006.01) Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/074950 Priority application(s): WO2006/074950

29 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006205817-Orally disintegrating composition of olanzapine or donepezil

2006205808-Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors